934 Altered Peptide Ligands Derived from a Public P53 Neoantigen Confer Superior Immunogenicity As Off-the-shelf Vaccine Candidates
Andrew J Northcutt, Pakhi Birla,James O Wrabl, Keila Voortman-Sheetz, Gabe Fortunato, Sarah Voor, Vincent J Hilser, Amanda L Huff,Franck Housseau,Elizabeth M Jaffee,Shibin Zhou,Fred Bunz Regular and Young Investigator Award Abstracts（2025）
Johns Hopkins School of Medicine
原文链接
分享
引用
